UPDATE: STRYKER HIP JOINTS
Patent appeals court rules against Stryker Corp.

On January 31 2008, a U.S. patent appeals court ruled in favor of TriMed Inc. in a suit which accused Stryker Corp. of infringing its patent for an implantable device to be used for broken bones and joints, according to Reuters.

TriMed had accused Stryker, one of the biggest makers of artificial hips and knees, of selling a device for wrist fractures that infringed TriMed's patent for an implantable device that would attach to stable portions of broken bones and hold the fractured portions in place.

The lawyers in our Defective Drugs and Medical Devices unit are now reviewing cases involving Stryker hip implants. The Unit is uniquely qualified to handle such litigation, having won numerous cases involving dangerous pharmaceuticals and medical devices, including Vioxx, achieving a $13.5 million verdict against Merck & Co. The firm’s other active pharmaceutical litigations include actions against the manufacturers of Bextra, ReNu, Celebrex, Ortho Evra, Gadolinium dye and Medtronic's Sprint Fidelis Leads.

If you have experienced any problems with your Stryker Hip Implant, or if you are unsure of the model of your hip replacement, please complete the form below for a free case evaluation. We will be in touch shortly and look forward to addressing your concerns.

Click To Talk To Us Online

see also:

Stryker Recalls Implants Stryker Recalls Hip Implants Made in Ireland & Sold Here--Lawsuit info
Stryker recalls Irish-produced hip implant devices

Stryker's First Response to FDA Warning Learn from our lawyers about the FDA letter to Stryker
Information about the FDA letter to Stryker from our lawyers

News & Warnings Read the FDA Warning Letter re: Stryker Hip Implants.
FDA issues Warning Letter re: Stryker Hip Implants. Get the info here.